Inotiv, inc. bolsters pathology services with acquisition of histion, llc

West lafayette, ind., april 25, 2022 (globe newswire) -- inotiv, inc. (nasdaq: notv) (the “company”, “we”, “our” or “inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research models and related products and services, today announced the acquisition of histion, llc (“histion”), effective april 25, 2022. the acquisition is a strategic element of the company's expansion of its specialized pathology services.
NOTV Ratings Summary
NOTV Quant Ranking